Search research articles
Contact Us
Filters
Showing results (31-40 of 113) with videos related to
Page
of 12
Sort By:
Bioorganic & Medicinal Chemistry
|
December 9, 2023
Discovery and biological evaluation of novel dual PTP1B and ACP1 inhibitors for the treatment of insulin resistance
Bo Feng, Jie Zhang, Zhen Liu, et al.
Gastroenterology Report
|
October 16, 2015
Survival of patients with KRAS wild-type metastatic colorectal cancer is identical after sequential treatment with cetuximab and bevacizumab regardless of the sequence - A retrospective single-center study
Yanhong Deng, Yue Cai, Jiayu Lin, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
November 26, 2014
[Safety and efficacy analysis on modified FOLFOXIRI as first-line treatment for advanced colorectal cancer in China-single center experience]
Yue Cai, Huabin Hu, Wenjing Wang, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
December 11, 2014
Visceral adipose tissue and the risk of colorectal adenomas: a meta-analysis of observational studies
Huabin Hu, Yue Cai, Jin Huang, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
April 4, 2013
Nonsteroidal anti-inflammatory drug use and the risk of melanoma: a meta-analysis
Huabin Hu, Yangchun Xie, Guorong Yang, et al.
Chemical Biology & Drug Design
|
March 23, 2017
Design, synthesis, biological evaluation, and molecular docking of novel flavones as H<sub>3</sub> R inhibitors
Gang Wen, Qian Liu, Huabin Hu, et al.
British Journal of Hospital Medicine (London, England : 2005)
|
February 25, 2025
Combining Circulating Tumour DNA with Clinical Pathological Risk Factors for Developing Peritoneal Metastasis Prediction Model in Patients with Colorectal Cancer
Bohan Han, Huabin Hu, Jianwei Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 22, 2018
The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay
Jie Xia, Huabin Hu, Wenjie Xue, et al.
International Journal of Molecular Sciences
|
January 21, 2017
A Thoroughly Validated Virtual Screening Strategy for Discovery of Novel HDAC3 Inhibitors
Huabin Hu, Jie Xia, Dongmei Wang, et al.
European Journal of Medicinal Chemistry
|
December 4, 2024
Identification of bioactive compounds with popular single-atom modifications: Comprehensive analysis and implications for compound design
Bo Feng, Hui Yu, Xu Dong, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 113) with videos related to
Sort By:
Page
of 12
Bioorganic & Medicinal Chemistry
|
December 9, 2023
Discovery and biological evaluation of novel dual PTP1B and ACP1 inhibitors for the treatment of insulin resistance
Bo Feng, Jie Zhang, Zhen Liu, et al.
Gastroenterology Report
|
October 16, 2015
Survival of patients with KRAS wild-type metastatic colorectal cancer is identical after sequential treatment with cetuximab and bevacizumab regardless of the sequence - A retrospective single-center study
Yanhong Deng, Yue Cai, Jiayu Lin, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|
November 26, 2014
[Safety and efficacy analysis on modified FOLFOXIRI as first-line treatment for advanced colorectal cancer in China-single center experience]
Yue Cai, Huabin Hu, Wenjing Wang, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
December 11, 2014
Visceral adipose tissue and the risk of colorectal adenomas: a meta-analysis of observational studies
Huabin Hu, Yue Cai, Jin Huang, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
April 4, 2013
Nonsteroidal anti-inflammatory drug use and the risk of melanoma: a meta-analysis
Huabin Hu, Yangchun Xie, Guorong Yang, et al.
Chemical Biology & Drug Design
|
March 23, 2017
Design, synthesis, biological evaluation, and molecular docking of novel flavones as H<sub>3</sub> R inhibitors
Gang Wen, Qian Liu, Huabin Hu, et al.
British Journal of Hospital Medicine (London, England : 2005)
|
February 25, 2025
Combining Circulating Tumour DNA with Clinical Pathological Risk Factors for Developing Peritoneal Metastasis Prediction Model in Patients with Colorectal Cancer
Bohan Han, Huabin Hu, Jianwei Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 22, 2018
The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay
Jie Xia, Huabin Hu, Wenjie Xue, et al.
International Journal of Molecular Sciences
|
January 21, 2017
A Thoroughly Validated Virtual Screening Strategy for Discovery of Novel HDAC3 Inhibitors
Huabin Hu, Jie Xia, Dongmei Wang, et al.
European Journal of Medicinal Chemistry
|
December 4, 2024
Identification of bioactive compounds with popular single-atom modifications: Comprehensive analysis and implications for compound design
Bo Feng, Hui Yu, Xu Dong, et al.
Page
of 12